Literature DB >> 2524678

Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study.

K A Bamford1, E D Caine, D K Kido, W M Plassche, I Shoulson.   

Abstract

To examine the premise that cognitive impairment in Huntington's disease (HD) is related to striatal degeneration, we determined those cognitive deficits most closely associated with linear CT indices of brain atrophy in HD. We systematically evaluated 60 drug-free HD patients who were judged to be in stages I (n = 34) or II (n = 26) of illness. All subjects underwent comprehensive neuropsychological assessment covering a broad spectrum of cognitive operations and standardized head CT imaging for determination of frontal horn (FH), intercaudate (CC), and outer-table (OT) distances. We grouped the cognitive test results, based on a principal-component factor analysis, to form factors 1 (complex psychomotor), 2 (verbal memory), 3 (visuospatial), and 4 (general knowledge). Factors 1 and 3 sharply discriminated between subjects in stages I and II of illness. Factors 1, 2, and 3 correlated strongly with CC/OT, an index of caudate atrophy, whereas only factor 2 correlated with FH/OT, an index of frontal atrophy. These data demonstrate that cognitive impairment is a clear-cut characteristic of early HD that is linked closely to the extent of caudate atrophy as measured by CT.

Entities:  

Mesh:

Year:  1989        PMID: 2524678     DOI: 10.1212/wnl.39.6.796

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  Visual processing disorders in patients with Huntington's disease and asymptomatic carriers.

Authors:  E Gómez-Tortosa; A del Barrio; T Barroso; P J García Ruiz
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 3.  Brain imaging and cognitive dysfunctions in Huntington's disease.

Authors:  Alonso Montoya; Bruce H Price; Matthew Menear; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

4.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

5.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

7.  Expression analysis of novel striatal-enriched genes in Huntington disease.

Authors:  Gelareh Mazarei; Scott J Neal; Kristina Becanovic; Ruth Luthi-Carter; Elizabeth M Simpson; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

Review 8.  Mitochondrial structural and functional dynamics in Huntington's disease.

Authors:  P Hemachandra Reddy; Peizhong Mao; Maria Manczak
Journal:  Brain Res Rev       Date:  2009-04-24

Review 9.  Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2009-04-28       Impact factor: 5.590

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.